A Phase 3 Study of IN10018 in Combination With D-1553 Versus Standard Therapy for First Line Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation
A Phase 3 Study of IN10018 in Combination With D-1553 Versus Standard Therapy for First Line Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation
Recruiting · NCT07174908 · Registry updated 2026-03-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 3 Study of IN10018 in Combination With D-1553 Versus Standard Therapy for First Line Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 3 | 2026-03-03 | NCT07174908 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| InxMed (Shanghai) Co., Ltd. | 10 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Cancer Hospital | Beijing | China | 55 |
| First Affiliated Hospital of Gannan Medical University | Gannan | China | 1 |
| Henan Cancer Hospital | Zhengzhou | China | 98 |
| Hunan Cancer Hospital | Changsha | China | 87 |
| Jiangsu Cancer Hospital | Nanjing | China | 22 |
| Shanghai Chest Hospital | Shanghai | China | 31 |
| The First Affiliated Hospital of Nanchang University | Nanchang | China | 77 |
| The First Affiliated Hospital of Zhengzhou University | Zhengzhou | China | 103 |
| The First Affiliated Hospital, Sun Yat-sen University | Guangzhou | China | 20 |
| Union Hospital Tongji Medidcal College Huazhong University of Science and Technology | Wuhan | China | 1 |
| Zhejiang Cancer Hospital | Hangzhou | China | 34 |